HRV and Anxiety

The Neurovisceral Integration Model

Julian Thayer's neurovisceral integration model provides the theoretical framework that most anxiety-HRV research builds on. The model proposes that the prefrontal cortex, the vagus nerve, and the heart form an integrated circuit. When the prefrontal cortex is functioning well, it exerts top-down inhibitory control over threat responses via the vagus nerve. Heart rate stays moderate, variability stays high, and the body maintains a flexible readiness to respond to the environment without overreacting.

In anxiety, this circuit is disrupted. The prefrontal cortex loses its regulatory grip, vagal tone decreases, and the heart shifts into a pattern of reduced variability and elevated rate. The body behaves as if threats are constant, even when the environment is objectively safe. Low HRV in this context is not a symptom — it is the physiological mechanism through which anxiety manifests in the body.

What the Research Shows

Meta-analyses consistently find that individuals with anxiety disorders have significantly lower resting HRV compared to healthy controls. This holds across generalised anxiety disorder, social anxiety, panic disorder, and PTSD. The effect sizes are moderate to large, and the finding replicates across studies, populations, and measurement methods.

A 2014 meta-analysis by Chalmers et al. examined 36 studies and found that anxiety disorders were associated with significant reductions in high-frequency HRV (the parasympathetic marker) and increases in heart rate. The effect was not limited to clinical populations — subclinical anxiety and trait anxiety also showed reduced HRV, suggesting the relationship exists on a continuum rather than only at diagnostic thresholds.

More recent work has extended these findings to show that low HRV is not just a correlate of anxiety but a predictor. Individuals with lower resting HRV are more likely to develop anxiety symptoms over time, and HRV measured during stressful tasks predicts how well someone will regulate their emotional response.

Depression, PTSD, and the Transdiagnostic Pattern

Reduced HRV is not unique to anxiety. It appears across depression, PTSD, and other conditions characterised by poor emotional regulation. This has led researchers to describe low HRV as a transdiagnostic marker — a shared physiological feature of multiple mental health conditions, reflecting a common underlying deficit in vagal regulatory capacity.

For PTSD specifically, the pattern is striking. Trauma survivors with PTSD show persistently low HRV even at rest, reflecting a nervous system stuck in a defensive, hypervigilant state. The vagal brake is chronically disengaged. The body cannot distinguish safety from threat. HRV biofeedback and vagus nerve stimulation have both been explored as interventions precisely because they target this vagal mechanism directly.

Vagus Nerve Stimulation and Anxiety

Because low HRV in anxiety reflects reduced vagal tone, interventions that strengthen vagal function have a clear mechanistic rationale. This is not speculative — it follows directly from the neurovisceral integration model and is supported by a growing body of clinical evidence.

A 2023 meta-analysis of 12 randomised controlled trials involving 838 participants found that transcutaneous auricular vagus nerve stimulation (taVNS) significantly reduced depression scores, with emerging evidence for anxiety reduction as well. The mechanism appears to involve restoration of prefrontal-vagal regulatory function — essentially re-engaging the vagal brake that anxiety has released.

Our own customer data aligns with this. Anxiety reduction is consistently reported alongside sleep improvement as one of the two most common outcomes. Users describe feeling calmer, less reactive, and better able to manage stressful situations — language that maps directly onto what improved vagal regulation would produce.